A drug and alcohol screening is a test that checks whether specific substances are present in your body. It uses a biological sample, most commonly urine, to detect traces of drugs or alcohol consumed over a recent period. Screenings are used in workplaces, medical settings, legal proceedings, and addiction treatment programs to quickly identify substance use without making a formal diagnosis.
What a Screening Actually Tests For
Most standard screenings check for a core group of substances. The federal government’s testing panel, which sets the baseline for most workplace programs, currently covers marijuana, cocaine, opioids (including fentanyl, oxycodone, and heroin markers), amphetamines (including MDMA), and PCP. This is sometimes called a “5-panel” test, though it actually checks for several drugs within each category.
Employers and courts can expand the panel. A 10-panel test typically adds benzodiazepines (anti-anxiety medications), barbiturates, methadone, and other prescription drugs. Alcohol testing is often handled separately, using breath testing for current impairment or a urine test for a byproduct called EtG that can detect drinking up to 48 to 72 hours after the fact.
How the Sample Is Collected
The type of sample determines how far back the test can look. Each method has a different detection window:
- Urine: The most common method. Detects most drugs within a 1 to 3 day window, though marijuana can show up for up to 30 days with chronic use, and barbiturates for up to 6 weeks.
- Oral fluid (saliva): A mouth swab that detects very recent use, typically within 1 to 36 hours. Federal guidelines now authorize oral fluid testing as an alternative to urine for workplace programs.
- Hair: Offers the longest detection window at 90 days or more. A small sample is cut close to the scalp. Hair tests are less common but sometimes used when a longer history matters.
- Blood: The most invasive option and generally reserved for medical or legal situations. It’s highly accurate but only captures substances present in the bloodstream at the time of the draw.
- Breath: Used exclusively for alcohol. A breathalyzer measures current impairment, not past drinking.
The Two-Step Lab Process
Drug screenings use a two-tier testing system. The first step is an immunoassay, a fast, relatively inexpensive test that flags samples above a set concentration threshold. For example, the federal cutoff for marijuana on a urine screen is 50 nanograms per milliliter. If your sample falls below that number, it’s reported as negative even if trace amounts are technically present.
If the initial screen comes back positive, the sample moves to a second, more precise test called mass spectrometry. This confirmatory step identifies the exact substance and its concentration, weeding out false positives from the initial screen. A result isn’t reported as positive until it clears both steps. The confirmatory cutoffs are often lower than the initial screen. For marijuana, the confirmation threshold drops to 15 ng/mL.
This two-step approach exists because immunoassays, while fast, can react to substances that are chemically similar to the target drug. The confirmatory test eliminates that ambiguity.
Why False Positives Happen
A number of common medications can trigger a positive result on the initial immunoassay screen. False positives for amphetamines are the most frequently reported, and the list of medications that can cause them is surprisingly long: the antidepressants bupropion, trazodone, venlafaxine, and sertraline; the cough suppressant dextromethorphan; the allergy medications diphenhydramine and brompheniramine; the pain relievers ibuprofen and naproxen; and even the heartburn drug ranitidine.
False positives have also been documented for opioids, PCP, barbiturates, marijuana, benzodiazepines, and methadone in people taking other common prescription or over-the-counter drugs. This is exactly why the confirmatory test matters. If you’re taking any medication and are asked to complete a screening, disclosing your prescriptions to the testing provider (often called a Medical Review Officer) ensures an initial positive can be properly evaluated before it’s reported to your employer or the requesting party.
When and Why Screenings Are Required
The context determines what triggers a screening. In the workplace, the Department of Transportation requires testing for anyone in a safety-sensitive role, including commercial truck drivers, pilots, and transit operators. These workers face testing at six distinct points: before being hired, at random intervals, when a supervisor has reasonable suspicion of impairment, after certain accidents, before returning to duty after a violation, and during follow-up monitoring. Follow-up testing after a positive result requires a minimum of six directly observed tests over 12 months and can extend for up to five years.
Private employers outside of DOT-regulated industries set their own policies. Pre-employment screening is the most common, but some companies also conduct random or post-accident testing depending on state law and company policy. The substances tested and the consequences of a positive result vary widely.
In medical settings, screening serves a different purpose. The goal is early identification of risky substance use patterns before they cause serious health problems. Universal screening, where every patient is asked the same questions and offered the same tests regardless of appearance or background, is now considered best practice because it avoids singling out specific patients. Medical screenings typically combine lab results with a brief questionnaire about drinking and drug use habits. A positive screen doesn’t establish a diagnosis; it flags the need for a more thorough assessment.
Courts and probation programs use screenings to monitor compliance with sobriety requirements. These programs often rely on frequent, sometimes random, urine or oral fluid tests and may use EtG testing specifically because it can catch alcohol consumption days after drinking, long after a breathalyzer would read zero.
Detection Windows for Common Substances
How long a drug stays detectable depends on the substance, how heavily it was used, your metabolism, and the type of test. For standard urine screening, these are the typical detection windows:
- Marijuana: 1 to 3 days for occasional use, up to 30 days for daily use
- Cocaine: 2 to 4 days, extending to 10 to 22 days with heavy use
- Amphetamines and MDMA: 1 to 2 days
- Opioids (heroin, morphine, codeine): 1 to 2 days
- Oxycodone: 1 to 1.5 days
- Fentanyl: 1 to 2 days
- Methadone: 2 to 11 days
- Benzodiazepines: 1 to 3 days for short-term use, up to 6 weeks with heavy, long-term use
- Barbiturates: Up to 6 weeks
Hair testing extends all of these windows to roughly 90 days. Oral fluid testing compresses them to hours rather than days, making it better suited for detecting very recent use. The right test for the situation depends on whether the goal is catching current impairment, recent use, or a longer pattern of consumption.
What Happens After a Positive Result
A confirmed positive in a workplace setting is typically reviewed by a Medical Review Officer, a licensed physician who contacts you to determine whether there’s a legitimate medical explanation, such as a valid prescription. If the positive is explained by a documented prescription taken as directed, it’s generally reported as negative to the employer.
If no medical explanation exists, the consequences depend on the context. In DOT-regulated positions, you’re immediately removed from safety-sensitive duties and referred to a substance abuse professional before you can return. In non-regulated workplaces, the response ranges from termination to referral to an employee assistance program, depending on company policy. In legal and probation settings, a confirmed positive may result in sanctions, modified conditions, or required treatment enrollment.